OTC brand name product extensions continue to cause confusion

March 2007

Please see updated information from the FDA regarding Maalox OTC brand name product extensions continue to cause confusion......

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
300+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscription Options

Already a subscriber? Log in

Volume pricing available. Get quote

Table of Contents

recommend a bowel prep for patients having a colonoscopy
Supplements People are asking if they should take MORE vitamin D and LESS calcium
Supplements hear more about Cold-fX now that Health Canada will allow more substantial claims
electronic prescribing in Canada
Infectious Diseases recommendations for treating community-acquired pneumonia in adults
Cardiology new category of antihypertensives called direct renin inhibitors
OTC Products OTC version of orlistat (Xenical) is generating questions
OTC Products OTC brand name product extensions continue to cause confusion
Kidney Disease minimize the risk of kidney damage due to the contrast dyes used for diagnostic tests
Women s Health whether the newer low-dose oral contraceptives are less effective
if their meds can cause weight gain
Smoking Cessation Resolve is a new natural smoking cessation product
Gastroenterology both a proton pump inhibitor PLUS an H2-blocker for GERD